Maternal complement C1q and increased odds for psychosis in adult offspring

Schizophrenia Research

Volumn 159, Issue 1, 2014, Pages 14-19

  Severance, Emily G ^a   Gressitt, Kristin L ^a   Buka, Stephen L ^b   Cannon, Tyrone D ^c   Yolken, Robert H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Inflammation; Innate immune activation; Maternal exposure; Maternal fetal interface; Synapses

Indexed keywords

C REACTIVE PROTEIN; CASEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; FOOD ANTIGEN; GLUTEN; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; OVALBUMIN;

ADENOVIRUS; ADULT; ADULT CHILD; AFFECTIVE PSYCHOSIS; ARTICLE; BIRTH DATE; BIRTH HOSPITAL; CASE CONTROL STUDY; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MATERNAL AGE; MATERNAL SERUM; MATERNAL SERUM SCREENING TEST; MEASLES VIRUS; ONSET AGE; RACE; RISK FACTOR; SCHIZOPHRENIA; TOXOPLASMA GONDII; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD HYPERSENSITIVITY; IMMUNOLOGY; LONGITUDINAL STUDY; METABOLISM; MOTHER; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL EXPOSURE; PROSPECTIVE STUDY; PSYCHOTIC DISORDERS; YOUNG ADULT;

ADULT CHILDREN; CASE-CONTROL STUDIES; COMPLEMENT C1Q; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; LONGITUDINAL STUDIES; MOTHERS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84907981195     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.07.053     Document Type: Article

References (50)

1. Arakelyan A., Zakharyan R., Khoyetsyan A., Poghosyan D., Aroutiounian R., Mrazek F., Petrek M., Boyajyan A. Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. BMC Clin. Pathol. 2011, 11:10.
2. Bauman M.D., Iosif A.M., Smith S.E., Bregere C., Amaral D.G., Patterson P.H. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol. Psychiatry 2014, 75(4):332-341.
3. Benoit M.E., Tenner A.J. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J. Neurosci. 2011, 31(9):3459-3469.
4. Bialas A.R., Stevens B. TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat. Neurosci. 2013, 16(12):1773-1782.
5. Blomstrom A., Karlsson H., Wicks S., Yang S., Yolken R.H., Dalman C. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring-a matched case-control study. Schizophr. Res. 2012, 140(1-3):25-30.
6. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64(1):93-109.
7. Boyajyan A., Khoyetsyan A., Tsakanova G., Sim R.B. Cryoglobulins as indicators of upregulated immune response in schizophrenia. Clin. Biochem. 2008, 41(6):355-360.
8. Braunschweig D., Krakowiak P., Duncanson P., Boyce R., Hansen R.L., Ashwood P., Hertz-Picciotto I., Pessah I.N., Van de Water J. Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl. Psychiatry 2013, 3:e277.
9. Brimberg L., Sadiq A., Gregersen P.K., Diamond B. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol. Psychiatry 2013, 18(11):1171-1177.
10. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280.
11. Brown A.S., Cohen P., Greenwald S., Susser E. Nonaffective psychosis after prenatal exposure to rubella. Am. J. Psychiatry 2000, 157(3):438-443.
12. Brown A.S., Schaefer C.A., Wyatt R.J., Goetz R., Begg M.D., Gorman J.M., Susser E.S. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr. Bull. 2000, 26(2):287-295.
13. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61(8):774-780.
14. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., Perrin M., Gorman J.M., Susser E.S. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2004, 161(5):889-895.
15. Buka S.L., Cannon T.D., Torrey E.F., Yolken R.H. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol. Psychiatry 2008, 63(8):809-815.
16. Bulla R., Bossi F., Tedesco F. The complement system at the embryo implantation site: friend or foe?. Front. Immunol. 2012, 3:55.
17. Canetta S., Sourander A., Surcel H.M., Hinkka-Yli-Salomaki S., Leiviska J., Kellendonk C., McKeague I.W., Brown A.S. Elevated maternal c-reactive protein and increased risk of schizophrenia in a national birth cohort. Am. J. Psychiatry 2014, (Epub ahead of print).
18. Cannon T.D., Rosso I.M., Hollister J.M., Bearden C.E., Sanchez L.E., Hadley T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr. Bull. 2000, 26(2):351-366.
19. Cannon T.D., Yolken R., Buka S., Torrey E.F. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol. Psychiatry 2008, 64(9):797-802.
20. Ellman L.M., Yolken R.H., Buka S.L., Torrey E.F., Cannon T.D. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol. Psychiatry 2009, 65(12):1040-1047.
21. Elmer B.M., Estes M.L., Barrow S.L., McAllister A.K. MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease. J. Neurosci. 2013, 33(34):13791-13804.
22. Fourgeaud L., Boulanger L.M. Synapse remodeling, compliments of the complement system. Cell 2007, 131(6):1034-1036.
23. Garbett K.A., Hsiao E.Y., Kalman S., Patterson P.H., Mirnics K. Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl. Psychiatry 2012, 2:e98.
24. Havik B., Le Hellard S., Rietschel M., Lybaek H., Djurovic S., Mattheisen M., Muhleisen T.W., Degenhardt F., Priebe L., Maier W., Breuer R., Schulze T.G., Agartz I., Melle I., Hansen T., Bramham C.R., Nothen M.M., Stevens B., Werge T., Andreassen O.A., Cichon S., Steen V.M. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol. Psychiatry 2011, 70(1):35-42.
25. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 2000, 290(5499):2155-2159.
26. Karlsson H., Blomstrom A., Wicks S., Yang S., Yolken R.H., Dalman C. Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am. J. Psychiatry 2012, 169(6):625-632.
27. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 2002, 25:409-432.
28. Mailian K.R., Boiadzhian A.S., Sogoian A.F., Sim R.B., Manukian L.A. Concentration and protein composition of circulating immune complexes in the blood of patients with schizophrenia and subjects with positive familial history of disease. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 2005, 105(4):55-60.
29. Malek A., Sager R., Kuhn P., Nicolaides K.H., Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 1996, 36(5):248-255.
30. Mayilyan K.R., Weinberger D.R., Sim R.B. The complement system in schizophrenia. Drug New Perspect. 2008, 21(4):200-210.
31. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:20-34.
32. Mortensen P.B., Pedersen C.B., Hougaard D.M., Norgaard-Petersen B., Mors O., Borglum A.D., Yolken R.H. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr. Res. 2010, 122(1-3):257-263.
33. Pedersen M.G., Stevens H., Pedersen C.B., Norgaard-Pedersen B., Mortensen P.B. Toxoplasma infection and later development of schizophrenia in mothers. Am. J. Psychiatry 2011, 168(8):814-821.
34. Piper M., Beneyto M., Burne T.H., Eyles D.W., Lewis D.A., McGrath J.J. The neurodevelopmental hypothesis of schizophrenia: convergent clues from epidemiology and neuropathology. Psychiatr. Clin. N. Am. 2012, 35(3):571-584.
35. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 2012, 17(12):1228-1238.
36. Severance E.G., Dickerson F.B., Halling M., Krivogorsky B., Haile L., Yang S., Stallings C.R., Origoni A.E., Bossis I., Xiao J., Dupont D., Haasnoot W., Yolken R.H. Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr. Res. 2010, 118(1-3):240-247.
37. Severance E.G., Alaedini A., Yang S., Halling M., Gressitt K.L., Stallings C.R., Origoni A.E., Vaughan C., Khushalani S., Leweke F.M., Dickerson F.B., Yolken R.H. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr. Res. 2012, 138(1):48-53.
38. Severance E.G., Gressitt K.L., Halling M., Stallings C.R., Origoni A.E., Vaughan C., Khushalani S., Alaedini A., Dupont D., Dickerson F.B., Yolken R.H. Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol. Dis. 2012, 48(3):447-453.
39. Severance E.G., Kannan G., Gressitt K.L., Xiao J., Alaedini A., Pletnikov M.V., Yolken R.H. Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS ONE 2012, 7(11):e50991.
40. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64(1):40-45.
41. Shi L., Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 2009, 23(1):116-123.
42. Simister N.E. Placental transport of immunoglobulin G. Vaccine 2003, 21(24):3365-3369.
43. Sontheimer R.D., Racila E., Racila D.M. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J. Investig. Dermatol. 2005, 125(1):14-23.
44. Stephan A.H., Madison D.V., Mateos J.M., Fraser D.A., Lovelett E.A., Coutellier L., Kim L., Tsai H.H., Huang E.J., Rowitch D.H., Berns D.S., Tenner A.J., Shamloo M., Barres B.A. A dramatic increase of C1q protein in the CNS during normal aging. J. Neurosci. 2013, 33(33):13460-13474.
45. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131(6):1164-1178.
46. Vetlugina T.P., Logvinovich G.V., Maslennikova S.N., Vasil'eva O.A. Circulating immune complexes in the serum of mental patients and healthy subjects. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 1984, 84(3):422-426.
47. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344(14):1058-1066.
48. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344(15):1140-1144.
49. Xiao J., Buka S.L., Cannon T.D., Suzuki Y., Viscidi R.P., Torrey E.F., Yolken R.H. Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect. 2009, 11(13):1011-1018.
50. Zakharyan R., Khoyetsyan A., Arakelyan A., Boyajyan A., Gevorgyan A., Stahelova A., Mrazek F., Petrek M. Association of C1QB gene polymorphism with schizophrenia in Armenian population. BMC Med. Genet. 2011, 12:126.